VALENSIN, PIER EGISTO
 Distribuzione geografica
Continente #
NA - Nord America 3.757
EU - Europa 2.528
AS - Asia 416
AF - Africa 8
OC - Oceania 7
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.721
Nazione #
US - Stati Uniti d'America 3.751
GB - Regno Unito 671
IE - Irlanda 574
CN - Cina 396
UA - Ucraina 367
SE - Svezia 335
DE - Germania 185
FR - Francia 172
FI - Finlandia 103
IT - Italia 70
ES - Italia 22
RU - Federazione Russa 8
BE - Belgio 6
CA - Canada 6
NL - Olanda 6
AU - Australia 5
VN - Vietnam 4
BR - Brasile 3
IR - Iran 3
JP - Giappone 3
LU - Lussemburgo 3
MW - Malawi 3
EG - Egitto 2
HK - Hong Kong 2
NZ - Nuova Zelanda 2
SC - Seychelles 2
SG - Singapore 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
MA - Marocco 1
PE - Perù 1
RS - Serbia 1
Totale 6.721
Città #
Southend 587
Fairfield 579
Dublin 568
Chandler 339
Ashburn 311
Jacksonville 294
Woodbridge 276
Menlo Park 252
Wilmington 208
Houston 205
Seattle 198
Cambridge 195
Ann Arbor 162
Princeton 101
Nanjing 97
Beijing 78
New York 61
Helsinki 44
Boardman 40
Nanchang 38
Shanghai 38
San Diego 31
San Mateo 25
Málaga 19
Siena 19
Hebei 18
Lancaster 18
Venezia 18
London 17
Tianjin 17
Jiaxing 14
Shenyang 14
Changsha 12
Norwalk 12
Washington 11
Dearborn 10
Kunming 10
Düsseldorf 8
Redwood City 8
Renton 7
San Francisco 7
Brussels 6
Fremont 6
Hangzhou 6
Jinan 6
Zhengzhou 6
Changchun 5
Guangzhou 5
Lanzhou 5
Toronto 5
Falls Church 4
Hanoi 4
Kilburn 4
Ningbo 4
Blantyre 3
Edinburgh 3
Falkenstein 3
Independence 3
Kazan 3
Luxembourg 3
Mestre 3
Prescot 3
Tappahannock 3
University Park 3
Cairo 2
Central 2
Chicago 2
Florence 2
Fuzhou 2
Groningen 2
Guagnano 2
Hendon 2
Hounslow 2
Izmir 2
Loreto 2
Mahé 2
Melbourne 2
Qingdao 2
Saint Petersburg 2
Sydney 2
Taizhou 2
Wandsworth 2
Acton 1
Amsterdam 1
Athens 1
Atlanta 1
Auburn Hills 1
Auckland 1
Augusta 1
Bari 1
Belgrade 1
Berlin 1
Budapest 1
Canberra 1
Chengdu 1
Chiswick 1
Concorezzo 1
Dubai 1
Evanston 1
Frankfurt am Main 1
Totale 5.116
Nome #
Serological evidence of reinfection among vaccinees during rubella outbreak. 166
Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis 164
The potential role of hepatitis C virus in the pathogenesis of the neurological syndrome in chronic hepatitis C 163
Antipeptide monoclonal antibodies inhibit the binding of rabiesvirus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor 161
Prevalence of skin allograft discards as a result of serological and molecular microbiological screening in a regional skin bank in Italy 159
Genotypic resistance to zidovudine as a predictor of failure of subsequent therapy with human immunodeficiency virus type 1 nucleoside reverse transcriptase inhibitors 144
Development and significance of the HIV-1 reverse transcriptase M184V mutation during combination therapy with lamivudine, zidovudine and protease inhibitors 141
Detection of genotypically drug-resistant HIV-1 variants and non-B subtypes in recently infected antiretroviral-naive adults in Italy. 141
Fast duplex one-step RT-PCR for rapid differential diagnosis of entero- or toscana virus meningitis 140
Characterization of immunoreactive octapeptides of human-cytomegalovirus gp58 138
Proprietà di legame di anticorpi monoclonali contro il virus della rabbia ottenuti per mezzo di immunizzazione con un peptide sintetico 137
Zidovudine resistance mutations and human immunodeficiency virus type 1 DNA burden: longitudinal evaluation of six patients under treatment 134
Antigenicity and immunogenicity of the V3 domain of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. AIDS Res Hum Retroviruses 134
Antipeptide monoclonal antibodies inhibit the binding of rabies virus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor 134
Microfilament and microtubule alterations in cultured CHO cells during methyl mercury intoxication and protection with selenite 133
Nested polymerase chain reaction for detection of human immunodeficiency virus type 1 DNA in clinical specimens. 130
Tumour associated antigen (TAA) specific cytotoxic T cell (CTL) response in vitro and in a mouse model, induced by TAA-plasmids delivered by influenza virosomes 128
Analysis of the HIV-1 nef gene in five intravenous drug users with long-term nonprogressive HIV-1 infection in Italy. 128
Biotechnology for virus vaccine design, production, and control 126
Antiretroviral therapy with protease inhibitors in human immunodeficiency virus type 1- and human herpesvirus 8 coinfected patients 126
Helicobacter pylori infection and infertility 125
Development and significance of resistance to protease inhibitors in HIV-1-infected adults under triple-drug therapy in clinical practice. 125
Evaluation of the presence of 2-LTR HIV-1 unintegrated DNA as a simple molecular predictor of disease progression. 123
Concordance between polymerase chain reaction and antibody detection in the diagnosis of human immunodeficiency virus type 1 infection. 122
Synthetic peptides of rubella E1 glycoprotein for serological assays 121
Hepatitis C virus infection and myositis: a polymerase chain reaction study 119
Increased reliability of 'selective PCR' using additionally mutated primers and a commercial 'Taq DNA polymerase enhancer' 119
Long-read direct infrared sequencing of crude PCR products for prediction of resistance to HIV-1 reverse transcriptase and protease inhibitors. 118
Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples 117
Low human immunodeficiency virus titer and polymerase chain reaction false-negatives 116
Rapid identification of Toscana virus by nested PCR during an outbreak in the Siena area of Italy 115
Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein 111
Longitudinal study in HIV/HCV-coinfected HAART-naive patients and role of HCV genotype 110
Treatment with lopinavir/ritonavir in heavily pretreated subjects failing multiple antiretroviral regimens in clinical practice 110
Specific antibody patterns over a two-year period after rubella immunization with RA 27/3 live attenuated vaccine 109
Optimal conditions for detection of human immunodeficiency virus type 1 DNA by polymerase chain reaction with nested primers 108
Identification of Mycobacterium tuberculosis complex, Mycobacterium avium and Mycobacterium intracellulare by selective nested polymerase chain reaction 104
Evaluation of cell-free and cell-associated peripheral blood HIV-1 RNA response to antiretroviral therapy 97
Lack of efficacy of ozone therapy in HIV infection 97
Human immunodeficiency virus-1 infection, homosexuality, and Kaposi-associated herpes-like DNA in peripheral blood mononuclear cells 94
Expression of recombinant E2 and C proteins of rubella virus in insect cells 93
Serological evidence of reinfection among vaccinees during rubella outbreak 93
Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis 90
NMR investigation of cell cultures: early detection of infection by Herpes simplex virus type 2 and transformation 89
Clinical evaluation of an in-house reverse transcription-competitive PCR for quantitation of human immunodeficiency virus type 1 plasma RNA. 87
Rapid detection and typing of circulating mumps virus by reverse transcription/polymerase chain reaction 87
Divergent distribution of HIV-1 drug-resistant variants on and off antiretroviral therapy 86
Streptococcus gordonii as a live vaccine vector [Lo Streptococcus gordonii come vettore di vaccini ricombinanti] 86
Live-cell immunofluorescence for detection of human immunodeficiency virus type 1 (HIV-1)-related antigens in peripheral blood mononuclear cells from HIV-1-seropositive individuals 84
Simultaneous amplification of multiple human immunodeficiency virus type 1 DNA sequences from clinical specimens by using nested-primer polymerase chain reaction 81
Low human immunodeficiency virus type 1 (HIV-1)DNA burden as a major cause for failure to detect HIV-1 DNA in clinical specimens by PCR 80
Comparative evaluation of three computerized algorithms for prediction of antiretroviral susceptibility from human immunodeficiency virus type 1 genotype 79
Evaluation of the specific immune response after anti-rubella vaccination [Valutazione della risposta immunitaria specifica dopo vaccinazione anti-rosolia] 78
Viral childhood gastroenteritis 78
Ultrasensitive in-house reverse transcription-competitive PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma 78
Expression of measles virus antigens in Streptococcus gordonii 71
Simultaneous amplification of multiple human immunodeficiency virus type 1 DNA sequences from clinical specimens by using nested-primer polymerase chain reaction 67
CD4+/CD45RA+ “naive” T cells and immunological response to influenza virus vaccine in B-cell chromnic lymphocitic leukemia patients 66
Rubella epidemiology over a 14-year period in Siena (Italy): a retrospective serological survey 66
Comparison of M-MLV reverse transcriptase and Tth polymerase activity in RT-PCR of samples with low virus burden 61
Binding properties of monoclonal antibodies to rabies virus 60
Totale 6.747
Categoria #
all - tutte 19.537
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.537


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019475 0 0 0 0 0 0 0 0 0 88 204 183
2019/20201.493 197 44 95 271 89 93 142 190 128 117 30 97
2020/2021987 50 191 18 97 33 136 25 155 127 42 74 39
2021/2022655 40 83 27 61 58 10 41 21 35 86 45 148
2022/20231.180 71 106 160 176 106 248 10 105 98 29 41 30
2023/2024815 24 20 99 54 28 285 285 15 3 2 0 0
Totale 6.747